1179361-84-2 Usage
General Description
Ethyl 1-amino-1H-imidazole-5-carboxylate is a chemical compound with the molecular formula C7H10N3O2. It is a derivative of imidazole, a five-membered heterocyclic ring containing two nitrogen atoms. ethyl 1-amino-1H-imidazole-5-carboxylate is commonly used in organic and medicinal chemistry as a building block in the synthesis of various pharmaceuticals and bioactive compounds. It has potential applications in the development of drugs for various therapeutic uses, including as antiviral, antibacterial, and antifungal agents. Ethyl 1-amino-1H-imidazole-5-carboxylate is also used as a precursor in the production of pharmaceutical intermediates and other organic compounds, making it an important reagent in the field of chemical synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 1179361-84-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,9,3,6 and 1 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1179361-84:
(9*1)+(8*1)+(7*7)+(6*9)+(5*3)+(4*6)+(3*1)+(2*8)+(1*4)=182
182 % 10 = 2
So 1179361-84-2 is a valid CAS Registry Number.
1179361-84-2Relevant articles and documents
ATR INHIBITORS AND USES THEREOF
-
Paragraph 00307; 00356, (2022/02/15)
The present disclosure relates to novel compounds useful as inhibitors of ATR kinase, as well as pharmaceutical compositions comprising these compounds and methods of treatment by administration of these compounds or the pharmaceutical compositions.
IRAK INHIBITORS AND USES THEREOF
-
Paragraph 00296, (2017/01/23)
The present invention provides compounds, compositions thereof, and methods of using the same for inhibiting one or more interleukin-1 receptor-associated kinases ("IRAK").
INHIBITORS OF PI3 KINASE
-
Page/Page column 120, (2011/08/08)
There is provided compounds of formula (I), wherein A1, A4, A4a, A5, B1, B1a, B2, B2a, B3, B3a, B4, B4a and R3 have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PI3-K and/or mTOR) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease.
